vs
ARTS WAY MANUFACTURING CO INC(ARTW)与Foghorn Therapeutics Inc.(FHTX)财务数据对比。点击上方公司名可切换其他公司
Foghorn Therapeutics Inc.的季度营收约是ARTS WAY MANUFACTURING CO INC的1.8倍($9.2M vs $5.1M),ARTS WAY MANUFACTURING CO INC净利率更高(-12.7% vs -234.3%,领先221.5%),Foghorn Therapeutics Inc.同比增速更快(223.8% vs -17.9%),过去两年Foghorn Therapeutics Inc.的营收复合增速更高(35.3% vs -5.9%)
雅氏威制造是美国的生产企业,主打农业机械、模块化建筑与刀具产品,旗下拥有雅氏威、雅氏威科研、美国硬质合金刀具多个品牌,该企业曾为凯斯纽荷兰代工生产原厂离心风机。
Foghorn Therapeutics是一家临床阶段生物技术企业,专注于开发靶向染色质调控系统的创新疗法,用于治疗多种癌症及其他严重疾病,目前推进多款靶向候选药物管线,通过自主研发与战略合作服务全球患者群体。
ARTW vs FHTX — 直观对比
营收规模更大
FHTX
是对方的1.8倍
$5.1M
营收增速更快
FHTX
高出241.7%
-17.9%
净利率更高
ARTW
高出221.5%
-234.3%
两年增速更快
FHTX
近两年复合增速
-5.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $5.1M | $9.2M |
| 净利润 | $-645.5K | $-21.7M |
| 毛利率 | 18.6% | — |
| 营业利润率 | -11.2% | -258.2% |
| 净利率 | -12.7% | -234.3% |
| 营收同比 | -17.9% | 223.8% |
| 净利润同比 | -177.6% | -11.1% |
| 每股收益(稀释后) | $-0.13 | $-0.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ARTW
FHTX
| Q4 25 | $5.1M | $9.2M | ||
| Q3 25 | $6.4M | $8.2M | ||
| Q2 25 | $6.3M | $7.6M | ||
| Q1 25 | $5.1M | $6.0M | ||
| Q4 24 | $6.2M | $2.9M | ||
| Q3 24 | $5.9M | $7.8M | ||
| Q2 24 | $6.7M | $6.9M | ||
| Q1 24 | $5.7M | $5.0M |
净利润
ARTW
FHTX
| Q4 25 | $-645.5K | $-21.7M | ||
| Q3 25 | $254.1K | $-15.8M | ||
| Q2 25 | $1.5M | $-17.9M | ||
| Q1 25 | $-55.8K | $-18.8M | ||
| Q4 24 | $832.0K | $-19.5M | ||
| Q3 24 | $-26.2K | $-19.1M | ||
| Q2 24 | $-33.3K | $-23.0M | ||
| Q1 24 | $-465.0K | $-25.0M |
毛利率
ARTW
FHTX
| Q4 25 | 18.6% | — | ||
| Q3 25 | 27.5% | — | ||
| Q2 25 | 32.5% | — | ||
| Q1 25 | 29.1% | — | ||
| Q4 24 | 36.1% | — | ||
| Q3 24 | 28.9% | — | ||
| Q2 24 | 28.3% | — | ||
| Q1 24 | 25.7% | — |
营业利润率
ARTW
FHTX
| Q4 25 | -11.2% | -258.2% | ||
| Q3 25 | 5.4% | -226.9% | ||
| Q2 25 | 8.1% | -279.2% | ||
| Q1 25 | 0.0% | -385.0% | ||
| Q4 24 | 8.4% | -840.5% | ||
| Q3 24 | 2.6% | -305.5% | ||
| Q2 24 | 2.5% | -386.6% | ||
| Q1 24 | -6.6% | -558.3% |
净利率
ARTW
FHTX
| Q4 25 | -12.7% | -234.3% | ||
| Q3 25 | 4.0% | -194.4% | ||
| Q2 25 | 23.4% | -237.3% | ||
| Q1 25 | -1.1% | -316.4% | ||
| Q4 24 | 13.5% | -682.9% | ||
| Q3 24 | -0.4% | -244.9% | ||
| Q2 24 | -0.5% | -333.6% | ||
| Q1 24 | -8.1% | -495.4% |
每股收益(稀释后)
ARTW
FHTX
| Q4 25 | $-0.13 | $-0.35 | ||
| Q3 25 | $0.05 | $-0.25 | ||
| Q2 25 | $0.29 | $-0.28 | ||
| Q1 25 | $-0.01 | $-0.30 | ||
| Q4 24 | $0.17 | $-0.23 | ||
| Q3 24 | $-0.01 | $-0.31 | ||
| Q2 24 | $-0.01 | $-0.45 | ||
| Q1 24 | $-0.09 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $4.8K | $80.9M |
| 总债务越低越好 | $2.5M | — |
| 股东权益账面价值 | $13.3M | $-108.5M |
| 总资产 | $22.5M | $198.1M |
| 负债/权益比越低杠杆越低 | 0.19× | — |
8季度趋势,按日历期对齐
现金及短期投资
ARTW
FHTX
| Q4 25 | $4.8K | $80.9M | ||
| Q3 25 | $6.0K | $89.3M | ||
| Q2 25 | $4.5K | $72.6M | ||
| Q1 25 | $4.1K | $61.0M | ||
| Q4 24 | $1.9K | $55.5M | ||
| Q3 24 | $5.1K | $57.7M | ||
| Q2 24 | $4.5K | $138.9M | ||
| Q1 24 | $2.5K | $79.3M |
总债务
ARTW
FHTX
| Q4 25 | $2.5M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $2.1M | — | ||
| Q3 24 | $2.7M | — | ||
| Q2 24 | $2.7M | — | ||
| Q1 24 | $2.7M | — |
股东权益
ARTW
FHTX
| Q4 25 | $13.3M | $-108.5M | ||
| Q3 25 | $13.9M | $-89.7M | ||
| Q2 25 | $13.6M | $-76.7M | ||
| Q1 25 | $12.1M | $-61.7M | ||
| Q4 24 | $12.1M | $-45.5M | ||
| Q3 24 | $11.3M | $-28.3M | ||
| Q2 24 | $11.2M | $-14.3M | ||
| Q1 24 | $11.2M | $-97.5M |
总资产
ARTW
FHTX
| Q4 25 | $22.5M | $198.1M | ||
| Q3 25 | $21.8M | $205.0M | ||
| Q2 25 | $20.9M | $226.2M | ||
| Q1 25 | $21.0M | $258.7M | ||
| Q4 24 | $21.2M | $284.0M | ||
| Q3 24 | $23.5M | $308.4M | ||
| Q2 24 | $23.2M | $328.6M | ||
| Q1 24 | $24.3M | $255.0M |
负债/权益比
ARTW
FHTX
| Q4 25 | 0.19× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.17× | — | ||
| Q3 24 | 0.24× | — | ||
| Q2 24 | 0.24× | — | ||
| Q1 24 | 0.24× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-889.2K | $-22.3M |
| 自由现金流经营现金流 - 资本支出 | $-1.0M | — |
| 自由现金流率自由现金流/营收 | -20.6% | — |
| 资本支出强度资本支出/营收 | 3.0% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-1.5M | — |
8季度趋势,按日历期对齐
经营现金流
ARTW
FHTX
| Q4 25 | $-889.2K | $-22.3M | ||
| Q3 25 | $-1.3M | $-18.9M | ||
| Q2 25 | $1.4M | $-21.0M | ||
| Q1 25 | $-101.8K | $-24.0M | ||
| Q4 24 | $1.2M | $-24.5M | ||
| Q3 24 | $282.4K | $-21.0M | ||
| Q2 24 | $1.2M | $-25.5M | ||
| Q1 24 | $-99.3K | $-29.3M |
自由现金流
ARTW
FHTX
| Q4 25 | $-1.0M | — | ||
| Q3 25 | $-1.5M | — | ||
| Q2 25 | $1.2M | $-21.0M | ||
| Q1 25 | $-184.5K | $-24.0M | ||
| Q4 24 | $1.1M | $-25.0M | ||
| Q3 24 | $180.5K | $-21.3M | ||
| Q2 24 | $1.0M | $-25.6M | ||
| Q1 24 | $-380.4K | $-29.4M |
自由现金流率
ARTW
FHTX
| Q4 25 | -20.6% | — | ||
| Q3 25 | -23.8% | — | ||
| Q2 25 | 19.3% | -278.2% | ||
| Q1 25 | -3.6% | -403.2% | ||
| Q4 24 | 17.6% | -875.3% | ||
| Q3 24 | 3.1% | -273.0% | ||
| Q2 24 | 15.1% | -371.0% | ||
| Q1 24 | -6.6% | -583.1% |
资本支出强度
ARTW
FHTX
| Q4 25 | 3.0% | 0.0% | ||
| Q3 25 | 4.1% | 0.0% | ||
| Q2 25 | 2.1% | 0.3% | ||
| Q1 25 | 1.6% | 0.5% | ||
| Q4 24 | 1.8% | 16.8% | ||
| Q3 24 | 1.7% | 4.0% | ||
| Q2 24 | 3.4% | 0.2% | ||
| Q1 24 | 4.9% | 2.0% |
现金转化率
ARTW
FHTX
| Q4 25 | — | — | ||
| Q3 25 | -4.99× | — | ||
| Q2 25 | 0.91× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.44× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARTW
| Agricultural Products | $2.8M | 55% |
| Modular Buildings | $2.2M | 44% |
FHTX
暂无分部数据